Ursprung des Netzwerks ersten Grades von Diane R. Guinta
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 36 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Diane R. Guinta
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chief Executive Officer President Director of Finance/CFO General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer President President General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Graduate Degree | |
Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
University of California, Davis | College/University | Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
Aerogen, Inc.
Aerogen, Inc. Medical SpecialtiesHealth Technology Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL. | Medical Specialties | Director/Board Member Chief Executive Officer General Counsel | |
VIVUS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Founder | |
University of Illinois | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
University of California, Santa Barbara | College/University | Undergraduate Degree Doctorate Degree | |
CORCEPT THERAPEUTICS INCORPORATED | Pharmaceuticals: Major | General Counsel Director/Board Member | |
San Jose State University | College/University | Undergraduate Degree Masters Business Admin | |
CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chairman Founder | |
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Director/Board Member | |
Ilypsa, Inc.
Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
CERUS CORPORATION | Medical Specialties | Director/Board Member Chairman | |
RELYPSA INC | Pharmaceuticals: Major | Founder Founder | |
The University of Alabama at Birmingham | College/University | Doctorate Degree | |
Syracuse University | College/University | Undergraduate Degree | |
SRI International
SRI International Miscellaneous Commercial ServicesCommercial Services SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Human Resources Officer | |
University of Delaware | College/University | Undergraduate Degree | |
XOMA CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Aquila Consulting Group Ltd. | Corporate Officer/Principal | ||
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The University of California, San Francisco | College/University | Corporate Officer/Principal | |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal | |
UCSF School of Medicine | College/University | Doctorate Degree | |
COMERA LIFE SCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
FORTE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Pharmaceuticals: Major | Director/Board Member | |
PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 48 |
Irland | 2 |
Vereinigtes Königreich | 2 |
Kanada | 2 |
Sektoral
Health Technology | 34 |
Consumer Services | 15 |
Commercial Services | 3 |
Operativ
Director/Board Member | 140 |
Corporate Officer/Principal | 76 |
Independent Dir/Board Member | 45 |
Undergraduate Degree | 39 |
Chairman | 33 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Ernest Mario | 44 |
Howard Rosen | 26 |
Phyllis Gardner | 19 |
Bruce Cozadd | 19 |
Martin S. Gerstel | 17 |
Matthew Fust | 16 |
James W. Young | 15 |
Barbara Finck | 15 |
Michael Miller | 14 |
Jeff Hargroves | 14 |
Peter Staple | 13 |
Jane E. Shaw | 12 |
Nandan Oza | 11 |
Daniel Swisher | 10 |
Detlef F. Albrecht | 10 |
- Börse
- Insiders
- Diane R. Guinta
- Unternehmensverbindungen